FIELD: chemistry.
SUBSTANCE: invention refers to applications of compound of formula
I or its pharmaceutically acceptable salt: where R1, R2, R7 and R8 stand for C1-C10 alkyl group, etc.; R3, R4, R5, R6, R9, R10, R11 and R12 stand for hydrogen atom, C1-C6 alkyl group, aryl group, etc.; X1 and X2 stand for C1-C15 alkyl group or aryl group, and X1 and X2 together contain 0 to 4 carboxyl groups; m1, m2 and m3 stand for 0 or 1; L1~L7 independently stand for methine group; M stands for hydrogen, metal atom, or quaternary ammonium salt; n stands for integer 1 to 7 required to neutralise the charge, to produce fluorescent contrasting near infrared agent used in fluorescent body imaging method; actually fluorescent contrasting near infrared agent containing compound of formula I or its pharmaceutically acceptable salt.
EFFECT: use of aforesaid compound to produce contrasting agents enables to produce quickly high-detail contrast images in living organism research.
11 cl, 16 ex, 8 dwg
Title | Year | Author | Number |
---|---|---|---|
OXYSTEROLS AND THEIR APPLICATION METHODS | 2017 |
|
RU2754130C2 |
HETEROARYLCARBOXYLIC ACID ESTER DERIVATIVES | 2013 |
|
RU2664544C2 |
ANTITUMOUR COMPOUNDS | 2008 |
|
RU2528393C9 |
METHOD OF PRODUCING THIOPHENE DERIVATIVE AND INTERMEDIATE PRODUCT THEREOF | 2009 |
|
RU2495877C2 |
ANTITUMORAL COMPOUNDS | 2008 |
|
RU2489429C2 |
CA-IX SPECIFIC RADIOPHARMACEUTICAL AGENTS FOR TREATING AND IMAGING MALIGNANT TUMOURS | 2009 |
|
RU2539565C2 |
ANTICANCER DIHYDROPYRAN-3-ONE COMPOUNDS | 2007 |
|
RU2444519C2 |
CATALYSTS | 2015 |
|
RU2706004C2 |
COMPOSITIONS AND METHODS FOR TREATING OCULAR EDEMA, NEOVASCULARISATION AND RELATED DISEASES | 2011 |
|
RU2600794C2 |
OXYSTEROLES AND METHODS OF USING THEM | 2016 |
|
RU2742333C2 |
Authors
Dates
2009-03-27—Published
2003-03-07—Filed